Astellas and YASKAWA to establish JV focused on cell therapy manufacturing
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
Notably, 36 female students have been placed in Production and Manufacturing roles, reflecting the growing representation of women in core biotech operations
The session focused on “Biomanufacturing of Enzymes,” a critical domain under the BioE3 Policy.
The technical program will run in four sessions and a panel discussion on “Challenges in translation of medical technologies”
Acquisition to advance company's next generation biology portfolio with internationally recognized pioneer in organoid development
This partnership is set to meet the growing demand for innovative life science research solutions in the Vietnamese market
Buckley served as Chairman and Chief Executive Officer at Vanguard from 2018 until his retirement in 2024
We now rank 3rd in pharmaceutical production by volume and 14th by value
A new initiative to contribute to enhancing drug discovery capabilities in the field of gene and cell therapy in Japan
Subscribe To Our Newsletter & Stay Updated